Reversal for Respiratory Depression: Let’s Take a Breath!
- 7 May 2024
- journal article
- editorial
- Published by Wolters Kluwer Health in Anesthesiology
- Vol. 140 (6) , 1059-1061
Abstract
ANESTHESIOLOGY is the highest-impact, peer-reviewed medical journal that publishes trusted evidence that transforms the practice of perioperative,Keywords
This publication has 11 references indexed in Scilit:
- Time to Wake Up! The Ongoing Search for General Anesthetic Reversal AgentsAnesthesiology, 2024
- Modulating anesthetic emergence with pathway-selective dopamine signalingCurrent Opinion in Anaesthesiology, 2023
- Clinical Practice Guidelines in Anesthesiology: Adjusting Our ExpectationsAnesthesiology, 2021
- Activation of orexin system facilitates anesthesia emergence and pain controlProceedings of the National Academy of Sciences, 2018
- Practice Guidelines for Moderate Procedural Sedation and Analgesia 2018Anesthesiology, 2018
- Reversal of opioid‐induced respiratory depression by BK‐channel blocker GAL021: A pharmacokinetic‐pharmacodynamic modeling study in healthy volunteersClinical Pharmacology & Therapeutics, 2015
- Respiratory stimulant drugs in the post-operative settingRespiratory Physiology & Neurobiology, 2013
- A New Look at the Respiratory Stimulant DoxapramCNS Drug Reviews, 2006
- Doxapram shortens recovery following sevoflurane anesthesiaCanadian Journal of Anesthesia/Journal canadien d'anesthésie, 2006
- The Ventilatory Stimulant Doxapram Inhibits TASK Tandem Pore (K2P) Potassium Channel Function but Does Not Affect Minimum Alveolar Anesthetic ConcentrationAnesthesia & Analgesia, 2006